Literature DB >> 26855531

Giant mediastinal carcinoid.

Sabita Jiwnani1, George Karimundackal1, C S Pramesh1.   

Abstract

Entities:  

Year:  2015        PMID: 26855531      PMCID: PMC4743190          DOI: 10.4103/0971-5851.166764

Source DB:  PubMed          Journal:  Indian J Med Paediatr Oncol        ISSN: 0971-5851


× No keyword cloud information.
A 25-year-old male was presented with cough. Computed tomography (CT) scan showed anterior mediastinal mass [Figure 1] encasing the aortic arch and left brachiocephalic vein with compression of the superior vena cava. CT-guided biopsy showed neuroendocrine tumor staining with chromogranin, synaptophysin, and neuron specific enolase. Postchemoradiotherapy positron emission tomography-CT scan revealed static disease [Figure 2]. At surgery, the mass could be dissected off the major vessels; the thrombosed left brachiocephalic vein was resected. Good collaterals obviated the need for vascular reconstruction. The patient recovered after a stormy postoperative course. Histopathology report showed neuroendocrine carcinoma, mitotic rate of 10/10 HPF, and MIB-1 proliferation index of 8-10%. On 5-year follow-up, the patient is asymptomatic and disease-free on CT scan.
Figure 1

Anterior mediastinal mass encasing arch aorta, left brachiocephalic vein, and compressing superior vena cava

Figure 2

Static disease post chemoradiotherapy

Anterior mediastinal mass encasing arch aorta, left brachiocephalic vein, and compressing superior vena cava Static disease post chemoradiotherapy Thymic carcinoids are rare, accounting for 2% of all carcinoids; often invading locally and metastasizing distantly. Complete surgical resection is potentially curative. Prognosis is correlated with the degree of differentiation and completeness of resection.
  1 in total

1.  Superior mediastinal typical carcinoid detected by 99mTc-MIBI SPECT/CT imaging: A case report.

Authors:  Chenghui Lu; Zenghua Wang; Guoqiang Wang; Xufu Wang; Xinfeng Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.